Environmental Scan Process

Similar documents
A Guide for Assessing Health Research Knowledge Translation (KT) Plans

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Health and Social Care Directorate. Indicator Process Guide. Published December 2017

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION

Canadian Task Force on Preventive Health Care Procedure Manual

JOB PROFILE JOB STORE # 220 TITLE: POLICY ANALYST (DEVELOPMENTAL) CLASSIFICATION: ADMINISTRATIVE OFFICER 18, 21 OR 24 PROGRAM

ISSUE BRIEF DEVELOPING A RAPID-RESPONSE PROGRAM FOR HEALTH SYSTEM DECISION-MAKERS IN CANADA

Guidance on conducting consultations in the HRA Internal HRA guidance only

CABINET DIRECTIVE ON STREAMLINING REGULATION

Guide for Advisors, Jurors and Assessors

THREE -YEAR STRATEGIC PLAN

Development of Needs Based Planning Models for Substance Use Services and Supports in Canada. Updated Project Summary

TIPS PREPARING AN EVALUATION STATEMENT OF WORK ABOUT TIPS

ARCHIVED - Evaluation Function in the Government of. Archived Content. Centre of Excellence for Evaluation Treasury Board of Canada Secretariat

FSC PROCEDURE. The Development and Approval of Controlled Wood National Risk Assessments. Forest Stewardship Council FSC-PRO V3-0 D1-0 EN

DRAFT FOR PUBLIC COMMENT Guidance Note for ESS10 Stakeholder Engagement and Information Disclosure

Evaluation Policy for GEF Funded Projects

For information or an update on the progress of the policy contact:

HEDIS Measures NCQA s 20 Years of Experience with Measurement

Circumpolar Action Plan: Conservation Strategy for the Polar Bear Implementation Table of Bilateral and Multilateral Actions

Value Messages: Developing, Incorporating, and Making Use of a Core Strategic Tool

Ontario s Submission to the National Energy Board Modernization Expert Panel

Public release of clinical information in drug submissions and medical device applications

Volunteering for Clinical Trials

CHAPTER 17. SERVICEABILITY AND ACCESSIBILITY OF EXTERNAL SECTOR STATISTICS

EUnetHTA. European network for Health Technology Assessment. European network for Health Technology Assessment JA

VETERINARY DRUGS DIRECTORATE HEALTH PRODUCTS AND FOOD BRANCH HEALTH CANADA STRATEGIC PLAN

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products.

SAI Performance Measurement Framework Implementation strategy

POLICY AND PROCEDURES ON SURVEY ADMINISTRATION UNC ESHELMAN SCHOOL OF PHARMACY

ISO New England - ISO New England Inc. Transmission, Markets and Services Tariff

A Guide for Developing Health Research Knowledge Translation (KT) Plans

Internal Management Consulting Competency Model Taxonomy

CSA Z1600 Emergency Management and Business Continuity Programs. IAPA Conference April 23, 2008 Ron Meyers, Canadian Standards Association

Canada's National Model Construction Codes Development System

DECISION ADOPTED BY THE CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY AT ITS NINTH MEETING

The Sector Skills Council for the Financial Services Industry. National Occupational Standards. Risk Management for the Financial Sector

PER13 PPP. Terms of Reference for consultancy on Public Private Partnerships in the Transport sector

Implementation Guide 2000

Request for Qualifications Research & Analytical Consultant(s) RELEASE DATE» January 2018

The Drug Safety and Effectiveness Network (DSEN) Dr. Diane Forbes, Associate Director, DSEN CAPT 2012 Annual Conference, May 8, 2012

ONE WINDOW COORDINATION PROCESS for Mineral Development Projects in Ontario

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines

WHO Prequalification of In Vitro Diagnostics Programme

Indicators on Violence against Children: Guidelines for Field Testing. UNICEF Child Protection Section, Programme Division, New York

Welcome Baby Impact Evaluation Request for Proposals FREQUENTLY ASKED QUESTIONS. Information Webinar

Ethical Governance Framework

Identification and Prioritisation of NHS England Policy Research Needs

Immunization Information System (IIS) Trainer Sample Role Description

REGIONAL HEALTH AUTHORITIES ACT

GLOBAL VACCINE SAFETY INITIATIVE TERMS OF REFERENCE

Supreme Audit Institutions Performance Measurement Framework

NHS GRAMPIAN FREEDOM OF INFORMATION (SCOTLAND) ACT 2002 POLICY STATEMENT (For Staff)

A Quality Assurance Framework for Knowledge Services Supporting NHSScotland

The Yale Open Data Access (YODA) Project: Lessons Learned in Data Sharing

Audit of Cultural Industries Branch

Disclaimer. 2

Quality Assurance in Clinical Trials

GEF Evaluation Office Ethical Guidelines

Economic and Social Council

IFC Policy and Performance Standards on Social and Environmental Sustainability Review and Update Overview of Consultation and Engagement Process

Joint Horizon Scanning for pharmaceuticals

IMDRF. Final Document. Regulatory Authority Assessor Competence and Training Requirements. IMDRF MDSAP Work Group

SCHEDULE C COMMUNICATIONS PROTOCOL

Marked as Read: The Story of the Ineffective Code of Conduct

POLICY AND ADMINISTRATIVE PROCEDURE PROCESS

ICMA PRACTICES FOR EFFECTIVE LOCAL GOVERNMENT LEADERSHIP Approved by the ICMA Executive Board June 2017; effective November 2017

Consumer, Carer and Community Participation and Engagement Policy

6. Cross-Cutting Issues Indicators

clarify the roles of the Department and minerals industry in consultation; and

POLICY ON MANAGING POLICIES, PROCEDURES AND GUIDANCE DOCUMENTS

FRAMEWORK FOR POLICY DEVELOPMENT

Portfolio Management Professional (PfMP)

STRATEGIC VISION FOR THE WORK OF ESCWA IN THE FIELD OF STATISTICS VERSION 2

Validation of RFI Reports V Nov 2017

The Drug Approval Process in Canada

Table of Contents. 1.0 Governance Introduction... 2

National, provincial, regional and municipal organizations, practitioners and members.

Maggie Jesse Tim Shie. Romy Bolton

12 th World Telecommunication/ICT Indicators Symposium (WTIS-14)

ISO INTERNATIONAL STANDARD. Risk management Principles and guidelines. Management du risque Principes et lignes directrices

Guide to Involving Proponents When Consulting First Nations

How to map excellence in research and technological development in Europe

Template for ToR for Transaction Advisory Services

Project Overview for the Rights Protection Mechanisms Survey Request for Proposal

PPP Decision Making Approaches and Tools

Open Government Implementation Plan (OGIP)

G4 DEVELOPMENT. Document 2 of 12 Statistics: Quantitative Online Feedback. Second G4 Public Comment Period: Submissions.

Work Plan for : Enhancing Audit Quality

Human Resources Specialist, Staffing and Recruitment - (14 Month Term)

A Guide to Clinical Coding Audit Best Practice Version 8.0

STRATEGY TO PROTECT AND ADVANCE INDIGENOUS WATER RIGHTS

RWE from pre-clinical to launch. RWE from pre-clinical to launch. Standard of care Unmet needs. Disease burden Budget impact.

Trial oversight SOP for HEY-sponsored CTIMPs

Work Placement Handbook for Graduate Diploma in New Zealand Immigration Advice

PRINCE Update. Changes to the manual. AXELOS.com. April 2017 PUBLIC

VENDOR RISK MANAGEMENT FCC SERVICES

2 nd Phase activities of the TDG Roadmap and Invitation for the nomination of EUDG members. Publication of the Inland TDG Risk Management framework

Exam Duration: 2 hours and 30 minutes

Quality Assessment and Indicators

Transcription:

CADTH Environmental Scan Process May 2015 Version 1.0

REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The following version control table, as well as the version number and date on the cover page, is to be updated when any updates or revisions are made. Section Revision Number Date Description of Changes Made Environmental Scan: Process i

TABLE OF CONTENTS REVISION HISTORY... i ABBREVIATIONS...iii 1. INTRODUCTION... 1 1.1 About the Product... 1 1.2 Scope... 1 1.3 Audience... 1 1.4 Purpose and Application for Decision-Making... 1 1.5 Transparency... 2 1.6 Timelines... 2 2. PROCESS... 3 2.1 Flow Chart... 3 2.2 Detailed Processes: Topic Identification Phase... 4 2.2.1 Topic Identification... 5 2.2.2 Topic Filtered for Relevance... 5 2.2.3 Topic Validation (Drug Topics)... 5 2.3 Detailed Processes: Refinement Phase... 6 2.3.1 Scoping Search and/or Consultation... 6 2.3.2 Refined Topic Proposal... 6 2.3.3 Topic Proposal Approval... 6 2.4 Detailed Processes: Research Phase... 7 2.4.1 Project Initiation... 7 2.4.2 Literature Search (Optional)... 7 2.4.3 Survey (Optional)... 7 2.4.4 Environmental Scan Draft 1... 8 2.4.5 Internal Review and Approvals... 8 2.5 Detailed Processes: External Review Phase... 9 2.5.1 External Review... 9 2.5.2 Revisions and Creation of Environmental Scan Draft 2... 9 2.5.3 Internal Review... 9 2.6 Detailed Processes: Delivery Phase...10 2.6.1 Final Report Sent to Customer...10 2.6.2 Publishing and Tools...10 2.6.3 Post Final Report...10 APPENDIX 1: DEFINITIONS...11 Environmental Scan: Process ii

ABBREVIATIONS DPAC ES HTA Drug Policy Advisory Committee Environmental Scan Health Technology Assessment Environmental Scan: Process iii

1. INTRODUCTION 1.1 About the Product CADTH conducts environmental scans of health care practices, processes, and protocols inside and outside of Canada. Environmental Scan reports inform decision-makers about the use of health technologies across jurisdictions, particularly with respect to practice variation and policy gaps. They also help guide topic selection for other CADTH products, such as our Health Technology Assessments (HTAs) and Optimal Use projects. Environmental scanning involves establishing and maintaining networks with key health care stakeholders and scanning the environment to better understand their policy, practice, and research issues, including how both innovative and older health care technologies are being used and reimbursed. To understand and gather information on current or projected future practices, the above networks may be surveyed to help inform Environmental Scan reports, and/or a scan of the published literature is performed. 1.2 Scope Topics selected for Environmental Scans must be of interest to a majority of CADTH stakeholders (see section 1.3: Audience). Topics suitable for Environmental Scan reports include policy, practice, and research issues, as well as current or projected utilization of the following: Drugs Devices Diagnostic tests Medical, surgical, and dental procedures. 1.3 Audience Environmental Scan reports are produced for federal, provincial, and territorial government health policy-makers and those working at regional health authorities and hospitals in Canada, who make decisions about the access to or reimbursement of medical technologies. Environmental Scan reports are freely available online at cadth.ca (embargo periods may apply). 1.4 Purpose and Application for Decision-Making The purpose of Environmental Scan reports is to provide an overview of current and/or projected policy, practice, and research issues, as well as the use of established or emerging health care technologies. Environmental Scans are intended to inform policy- and decisionmakers on how policy, practice, and research issues, or the access or reimbursement of specific technologies in other environments may be applicable to their own setting. Environmental Scans are not intended to provide a comprehensive evaluation; instead, they give a snapshot of existing or projected health care issues. Environmental Scan reports may also highlight the potential financial implications or other issues associated with the introduction, decision not to introduce, or establishment of criteria for using and/or reimbursing specific technologies. Environmental Scan reports are often prepared in response to specific requests received from CADTH stakeholders to support their decision-making. Topics selected must be issues of interest to a majority of Canadian jurisdictions. Environmental Scan reports should not be construed as a recommendation for or against the use of a particular health technology. Environmental Scan: Process 1

1.5 Transparency CADTH attempts to be as transparent as reasonably possible in the production of Environmental Scans. The three principles of transparency as defined by CADTH are: Soliciting feedback from those affected by CADTH reports whenever possible, given time constraints Facilitating the ability to reproduce or update CADTH reports by reporting: o methods used to create reports o sources searched and/or provided Publishing CADTH reports in the public domain. In each ES report, a copy of the survey questions (if a survey is conducted) is included. Due to time constraints, a limited attempt is also made to solicit external feedback and review of the report, including the following methods: CADTH Drug Policy Advisory Committee (DPAC) validates and prioritizes drug topics from a stakeholder perspective. If a survey is conducted, survey respondents are typically given the opportunity to comment on the report. Optional for drug topics: o The draft report may be posted for stakeholder comment and/or o The draft report may be externally peer-reviewed by a content expert. The information selected for possible inclusion in an Environmental Scan report is identified by CADTH, using one or both of the following methods: a limited literature search a survey of key health care stakeholders. Environmental Scan reports are freely posted on cadth.ca for anyone to access and review, although in exceptional circumstances, embargo periods may be considered. All drafts and working documents used to produce Environmental Scan reports are archived for 15 years and may be requested if required (with the exception of copyright-protected documents; confidential survey responses; or information provided in confidence by customers, manufacturers, or other agencies). 1.6 Timelines Exact timelines will be negotiated between a CADTH representative and the requestor; however, the approximate turnaround time for an Environmental Scan report is three to six months. Environmental Scan: Process 2

2. PROCESS The process may be revised to meet customer needs. 2.1 Flow Chart Figure 1: All Phases Flow Chart Environmental Scan: Process 3

2.2 Detailed Processes: Topic Identification Phase FIGURE 2: TOPIC IDENTIFICATION PHASE FLOW CHART Request Submitted by CADTH Program Development Officer or CADTH Expert or Advisory Committees Request Submitted by Health Canada Topic Identification Request Submitted by Liaison Officer Topic Filtered for Relevance NO Topic Does Not Proceed YES Legend Topic Validated NO Topic Does Not Proceed Start/End = Process = YES Decision Point = Environmental Scan: Process 4

2.2.1 Topic Identification Topics for Environmental Scans may be suggested by Health Canada, CADTH expert or advisory committees, or CADTH Program Development Officers, or may be raised as part of a larger CADTH project. Topics may also be submitted by CADTH Liaison Officers on behalf of publically funded Canadian health care decision-makers. 2.2.2 Topic Filtered for Relevance CADTH determines the national relevance and impact of the topic by conducting an informal survey among Liaison Officers via email or during a conference call (unless a request comes from DPAC; see section 2.2.3). This may include discussions with stakeholders and/or the requestor. In order for the topic to proceed, the request must have near consensus about national impact and relevance. Selection criteria for an Environmental Scan may include the following: Not a duplication of scans completed by other agencies Relevant to the Canadian health care context Significant disease burden Significant impact Interest from multiple jurisdictions. Topics chosen as relevant are moved to the next stage; otherwise, the topic does not proceed. 2.2.3 Topic Validation (Drug Topics) During validation, drug Topic Proposals are sent to DPAC to review, to determine whether to proceed with the topic, revise it, or move it to another product line (some topics may be realigned with other CADTH products). If a request regarding a drug topic is received from DPAC, it is based on input from senior provincial representatives, so national relevance and impact are implicit and filtering and validation are not required. Research and survey questions may be reviewed by DPAC at this time and refined where appropriate. Environmental Scan: Process 5

2.3 Detailed Processes: Refinement Phase FIGURE 3: REFINEMENT PHASE FLOW CHART Scoping Search/Consultation Refined Topic Proposal Process = Legend Decision Point = Requestor & CADTH Approval NO Topic Does Not Proceed as an ES Document = YES Start/End = 2.3.1 Scoping Search and/or Consultation Depending upon the topic, a scoping search of the literature is done by CADTH to determine what information is available, and/or a consultation with stakeholders is conducted to assist in refining the research and survey questions. 2.3.2 Refined Topic Proposal The method(s) proposed for gathering the information to be analyzed is finalized at this time by the CADTH project team, in consultation with the requestor. The approach can include a literature review, a survey of key health care stakeholders, or a combination of both methods. A Topic Proposal document is created, which includes the refined research question(s), survey questions (if required), the agreed-to timeline, and the methods. 2.3.3 Topic Proposal Approval The draft Topic Proposal is emailed to the requestor for approval and sign-off, before finalization. Once finalized, the Topic Proposal must be approved by CADTH. If the topic is not approved, it does not proceed, or is considered for another product line. Environmental Scan: Process 6

2.4 Detailed Processes: Research Phase FIGURE 4: RESEARCH PHASE FLOW CHART Project Initiation Literature Search (Optional) And/Or Survey (Optional) Environmental Scan Draft 1 Internal Review and Approvals Revisions Required Legend Process = Decision Point = NO Revisions 2.4.1 Project Initiation A project is created based on the approved Topic Proposal. If a survey has been chosen, further discussions will be held with the Liaison Officers, customer, and key stakeholders to ensure the right respondents are selected for the survey. 2.4.2 Literature Search (Optional) The scope and approach of the literature search is agreed upon by the project team. A limited (not systematic) literature search is conducted in agreed-upon resources (may include major biomedical databases and a focused Internet search). Once the search is complete, the information is sent for analysis. 2.4.3 Survey (Optional) If a survey is to be conducted, survey questions developed in the Topic Proposal are used to create the survey. In collaboration with CADTH s Liaison Officers, the survey is sent to the targeted respondents (see section 2.4.1), along with the forms for permission and consent to allow publication of survey findings. Completed survey results are compiled and analyzed. Environmental Scan: Process 7

2.4.4 Environmental Scan Draft 1 A draft is created that summarizes the information found using the Environmental Scan template and following CADTH style and copyright guidelines. A typical Environmental Scan contains: Background and context for the report Statement of the objectives of the Environmental Scan Methods and approach used Key findings pertaining to the research questions Conclusions References used for the report (survey and literature review) Survey questions (if applicable). 2.4.5 Internal Review and Approvals The draft report is internally reviewed and the references are checked to ensure: Research questions are addressed Analysis and conclusions are sound Citation details are accurate and references follow National Library of Medicine Citing Medicine bibliographic style guidelines Copyright guidelines were followed Permissions for any unpublished information have been received Language is clear, keeping in mind customer needs. Before moving to the next phase, the appropriate management approvals are given. Environmental Scan: Process 8

2.5 Detailed Processes: External Review Phase FIGURE 5: EXTERNAL REVIEW PHASE FLOW CHART External Review (Optional for Drug Topics) Revisions and Creation of Environmental Scan Draft 2 Internal Review Process = Legend Decision Point = YES CADTH Approval NO 2.5.1 External Review If a survey is conducted, survey respondents may be given the opportunity to comment on the report. At least one of the following methods for external feedback is conducted, unless it is a drug topic, in which case external feedback is optional: The internally reviewed draft is posted for stakeholder feedback and the customer is sent the draft or directed to the report posted on CADTH s website for comment. The report is externally peer-reviewed by a content expert. 2.5.2 Revisions and Creation of Environmental Scan Draft 2 If applicable, comments from the survey respondents, stakeholders, and content expert are incorporated, to create Draft 2 of the Environmental Scan report. 2.5.3 Internal Review A final internal review and reference check is conducted of Draft 2. This includes: Environmental Scan: Process 9

Reviewing stakeholder (if obtained) and requestor feedback to ensure that they are adequately addressed Ensuring citation details are accurate and references follow National Library of Medicine Citing Medicine bibliographic style guidelines Ensuring copyright guidelines are followed and all permissions have been received. This final draft is sent to CADTH management to approve. 2.6 Detailed Processes: Delivery Phase FIGURE 6: DELIVERY PHASE FLOW CHART Final Report Sent to Customer Legend Publishing & Tools Document = Process = Start/End = Post Final Report 2.6.1 Final Report Sent to Customer The final Environmental Scan report is sent to the original requestors for their review before it is posted. 2.6.2 Publishing and Tools The final Environmental Scan report is sent to CADTH s Publishing department for copy-editing, formatting, and translation. If requested by the customer or CADTH stakeholders, tools will be created to help disseminate report findings. 2.6.3 Post Final Report English and French versions of the Environmental Scan are posted on cadth.ca. Environmental Scan: Process 10

APPENDIX 1: DEFINITIONS Advisory Committees: CADTH s standing committees of Canadian jurisdictional representatives who provide advice and strategic direction to CADTH projects; e.g., the Drug Policy Advisory Committee for drugs. CADTH: The Canadian Agency for Drugs and Technologies in Health is an independent, notfor-profit agency funded by Canada s federal, provincial, and territorial governments. CADTH s role is to deliver reliable, timely, and credible evidence-based information and impartial advice to Canada s health care leaders and decision-makers through a variety of customized products and services. Customer: A CADTH customer is an entity or organization that requests CADTH s products or engages CADTH s services. (The customer is most often the first point of contact and requests knowledge from CADTH. The customers needs may vary with specific topics, and they may request and/or choose between different products, services, and suppliers. By expressing their needs, customers drive the knowledge that CADTH produces.) Drug Policy Advisory Committee (DPAC): CADTH s standing committee of Canadian jurisdictional representatives who provide advice to CADTH drug projects. DPAC members are primary customers for the products and services in the CADTH drug portfolio. DPAC has nominated members to sit on two working groups the Formulary Working Group and the Optimal Use Working Group that provide advice and direction to CADTH on drug portfolio projects. Health Care Technology: Technologies inclusive of drugs, medical devices, diagnostics (such as tests), procedures, programs, and public health activities. Jurisdictions: Include the federal, provincial, and territorial health ministries from across Canada. Reference Check: A review of all the sources cited in the document, ensuring that they are accurate and follow National Library of Medicine Citing Medicine bibliographic standards. Stakeholders: Stakeholders for the Environmental Scanning process are organizations, institutions, or individuals who have a strong and vested interest in specific CADTH projects and their outcomes. Stakeholders may include: federal, provincial, and territorial Ministries of Health hospitals and health institutions health regions patients, consumers, and caregivers health professionals industry. Tools: These are knowledge mobilization tools used to enable health care decision-makers to use the reports CADTH develops. Tools may include summaries, presentations, conferences or workshop materials, continuing education content, and interactive tools that allow decisionmakers to customize the guidance provided with their own information. Environmental Scan: Process 11